Targeting cancer by a chimeric nanoparticle formulation of Cisplatin and PI828, a PI3 kinase inhibitor

被引：0
|
作者：
Roy, Bhaskar [1 ]
Sengupta, Poulomi [1 ]
Dinulescu, Daniela [1 ]
Muto, Katherine [1 ]
Papa, Anne Laure [1 ]
Basu, Sudipta [1 ]
Sengupta, Shiladitya [1 ]
机构：
[1] Brigham & Womens Hosp, Cambridge, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1951
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1951
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression
    Rosenberg, Stephen A.
    Niglio, Scot A.
    Salehomoum, Negar
    Chan, Joseph L. -K.
    Jeong, Byeong-Seon
    Wen, Yu
    Li, Jiadong
    Fukui, Jami
    Chen, Suzie
    Shin, Seung-Shick
    Goydos, James S.
    TRANSLATIONAL ONCOLOGY, 2015, 8 (01): : 1 - 9
  • [22] Idelalisib Targeting the PI3 Kinase Pathway in Non-Hodgkin Lymphoma
    Sujobert, Pierre
    Rioufol, Catherine
    Salles, Gilles A.
    CANCER JOURNAL, 2016, 22 (01): : 12 - 16
  • [23] Finessing PI3 Kinase Assay Development
    Entwistle, Kevin
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2009, 29 (02): : 30 - 31
  • [24] A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
    Fan, Qi-Wen
    Knight, Zachary A.
    Goldenberg, David D.
    Yu, Wei
    Mostov, Keith E.
    Stokoe, David
    Shokat, Kevan M.
    Weiss, William A.
    CANCER CELL, 2006, 9 (05) : 341 - 349
  • [25] The PI3′ kinase pathway in interferon signaling
    Kaur, S
    Uddin, S
    Platanias, LC
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (12): : 780 - 787
  • [26] PI3 Kinase, mTOR, and AKT Pathways
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : S1059 - S1060
  • [27] PI3 Kinase Inhibitors in the Clinic: An Update
    Kurtz, Jean-Emmanuel
    Ray-Coquard, Isabelle
    ANTICANCER RESEARCH, 2012, 32 (07) : 2463 - 2470
  • [28] Brain penetrant PI3 kinase inhibitors
    Heffron, Timothy P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [29] PI3 KINASE INHIBITORS: PROGRESS AND CHALLENGES
    Workman, P.
    ANNALS OF ONCOLOGY, 2009, 20 : 25 - 25
  • [30] Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo
    ElMokh, Oussama
    Ruffieux-Daidie, Dorothee
    Roelli, Matthias A.
    Stooss, Amandine
    Phillips, Wayne A.
    Gertsch, Jurg
    Dettmer, Matthias S.
    Charles, Roch-Philippe
    ONCOTARGET, 2017, 8 (15) : 24604 - 24620
12345